From Ear to Knee – The Next Chapter of Regenerative Medicine
Written by Paul Lee, Regenerative Orthopedic Surgeon
Professor Paul Lee is a Harley Street Regenerative Orthopedic Surgeon specializing in cartilage and joint preservation. His work in helping patients understand what may still be possible before joint replacement has also shaped a broader systems-based approach to regeneration.
Some of medicine's most remarkable ideas begin with a simple question. If the aim is to repair cartilage, why not begin with cartilage itself? Across the world, people living with pain and cartilage damage are searching for answers about what may still be possible before joint replacement. Many have already researched regenerative treatments and stem cell therapy.
That interest is entirely understandable. Stem cells changed the public conversation by introducing a powerful idea: that medicine might work with the body's own biology rather than only remove or replace damaged tissue.
The next question is whether regeneration can become more precise. Rather than beginning with a general cell and asking it to become cartilage, could we begin with a cell that already belongs to cartilage?
This is where the journey from ear to knee begins. A very small sample of cartilage can be collected from behind the ear and carefully processed within the clinic, becoming part of a personalised approach to cartilage repair during the same visit.
From potential to precision
Stem cells are often described as unspecialised cells because they have the potential to develop along different biological pathways. This versatility is what has made them so exciting.
Cartilage cells, known as chondrocytes, offer a different form of potential. They are already specialised. They belong to the tissue we are trying to support.
One way to understand the difference is to imagine a building project. A stem cell is like a highly capable trainee who may be guided towards several different trades. A chondrocyte is more like a specialist who already understands cartilage. Both approaches can be valuable, but they begin from different biological starting points.
Tissue-specific regeneration does not reject the thinking behind stem cell therapy. It builds on it. It asks whether, when the target tissue is known, starting with the relevant specialised cell may offer a more direct and precise strategy.
Why the ear
Cartilage is found in several parts of the body, but it doesn't do the same job everywhere. Ear cartilage is flexible. Knee cartilage must create a smooth, durable surface that can tolerate movement and load. They are not identical tissues.
They share a family of cartilage cells. By obtaining a very small sample from behind the ear, it is possible to access the patient's own chondrocytes without taking the original sample from an already damaged knee.
The sample is not simply moved from the ear into the knee like a spare part. It passes through a carefully controlled point-of-care process within the clinic, preparing the patient's own cartilage cells for use as part of the treatment during the same visit. Because the cells come from the recipient, the process is autologous. The donor and the recipient are the same person.
Traditional autologous chondrocyte implantation, or ACI, introduced a powerful principle: use a patient's own cartilage cells to repair cartilage. It usually involves taking a sample from the knee, growing the cells in a laboratory over several weeks, and returning for a later implantation procedure. Here, the philosophy is reimagined as an ear-to-knee journey completed in one clinical visit.
This is what makes the concept so compelling. The biological starting material does not come from a donor or a synthetic source. It comes from the person being treated, with the journey from collection to preparation unfolding in the clinic during a single visit.
The seed, the soil, and the signal
Cells are important, but cells alone do not explain regeneration. A seed may contain potential, but it still needs suitable soil and the right signals from its environment.
In cartilage repair, the patient's own ear cartilage cells can provide the seed, prepared during the visit and known as Mytocel MSK. The soil can be created using a collagen scaffold called ChondroFiller, which provides a supportive structure within the damaged area. The signal can come from platelet-rich plasma (PRP) or platelet-rich fibrin (PRF), prepared from the patient's own blood and containing biological factors involved in the healing response.
Each element performs a different role. The cells provide the living component. The scaffold provides structure. The blood-derived preparation supports the biological environment.
This combined approach is known as NanoACI, but the name is less important than the philosophy. It is not about searching for one miracle ingredient. It is about bringing together the right cells, structure, and signals in a planned way.
The joint is more than cartilage
Even the most advanced cell treatment cannot be considered separately from the joint it is placed in. The knee is a moving, weight-bearing system shaped by cartilage, bone, ligaments, muscles, the meniscus, and how the person loads the joint.
An MRI can show cartilage damage, but it cannot fully explain how the person moves, what they feel, or why the damage developed. Two knees can appear similar on a scan and require very different decisions.
If a joint is unstable, poorly aligned, or repeatedly overloaded, treating one area of cartilage may not be enough. You must also understand the surrounding conditions. Regeneration is therefore not simply a treatment. It involves structure, movement, biology, and recovery.
This is why I do not believe in treating the image alone. We are not simply treating the joint. We are treating the patient.
What may still be possible before replacement
Joint replacement remains one of the most successful operations in modern medicine. Regenerative medicine is not about arguing against it. It is about understanding what may still be possible before replacement becomes the default.
In the Harley Street medical district, this is the question I increasingly hear from patients travelling from around the world: not simply what may eventually need replacing, but what can still be preserved, supported, or repaired now.
A joint rarely progresses from healthy to replacement overnight. A long period usually lies in between, during which cartilage, movement, symptoms, and function gradually change. That period may offer opportunities to preserve what remains, repair damaged areas, and support the joint more effectively.
No cell treatment suits every joint, and no biological procedure can guarantee cartilage regeneration. A localised area of damage in a stable joint is very different from widespread, advanced arthritis. Patient selection, timing, and the joint's overall condition remain fundamental.
The next chapter of regeneration
Stem cell therapy helped the world imagine that the body's own biology could become part of treatment. Tissue-specific regeneration takes that idea further by asking how precisely that biology can be selected, supported, and placed.
The future may not be defined by one cell type or one universal treatment. It is more likely to be defined by matching the right biological approach to the right tissue, joint, and person.
The exciting part is not simply that cells can travel from the ear to the knee. It is that we are learning how to use the body's own specialised materials with greater purpose and precision.
Read more from Paul Lee
Paul Lee, Regenerative Orthopedic Surgeon
Professor Paul Lee is a Harley Street Regenerative Orthopedic Surgeon, cartilage and joint preservation specialist, and founder of the London Cartilage Clinic. He has been recognized as an ICRS Teaching Centre of Excellence for cartilage and joint preservation surgery for over 10 years. His work focuses on what may still be preserved, repaired, or regenerated before joint replacement becomes the default, and this clinical philosophy has also shaped his wider regeneration platform, Regen PhD. He is an Honorary Professor of Sports Medicine at the University of Lincoln, editor of Springer’s Musculoskeletal Regeneration Medicine, and author of the international Amazon number 1 bestsellers Regeneration by Design and Practical Regeneration.
Disclaimer: This article is for general educational purposes and does not replace an individual medical assessment. Treatment suitability, expected outcomes, and risks vary between people.
